Every eighth child is projected to have a mental health condition. A number of predictors of children’s mental health problems have been identified, although much remains unknown. Previous study reveals that low vitamin D levels in children may be one factor contributing to an increased risk of mental health disorders later in life. A recent Finnish study, currently published in JAMA Network Open, adds to the body of knowledge about the relationship between vitamin D intake and mental health.
A recent study by a group of Finnish researchers looked into whether taking a daily vitamin D3 supplement at a higher level than the recommended dose in early childhood lessens the risk of psychiatric symptoms later in life.
The research is part of the Vitamin D Intervention in Infants (VIDI) clinical trial, which is looking into how early vitamin D3 supplementation affects children’s growth and development. The children in the study were divided into two groups, one receiving the daily standard dose of 10 micrograms and the other receiving treble the amount—30 g—of vitamin D. From the age of two weeks to two years, the children got the supplements on a daily basis.
The children were followed up on, and the most recent monitoring point occurred when they were between the ages of six and eight. In the most recent follow-up phase, the parents of 346 children completed a questionnaire to assess their child’s psychiatric symptoms.
The study discovered that taking more vitamin D3 than the recommended daily dose lowered the chance of internalizing difficulties in children. In other words, children who received the greater dose reported less low mood, anxiety, and withdrawn behavior from their parents than children who received the usual amount.
Parents’ Reports of Psychiatric Symptoms
According to the study findings, 11.8% of children who got the normal amount of daily vitamin D supplement of 10 g till the age of two years exhibited clinically significant internalizing issues. 5.6% of the youngsters who received the triple vitamin D supplement had comparable issues.
“Our results suggest that a higher dose of vitamin D3 supplementation during the first years of life may reduce the risk of internalizing psychiatric symptoms in late preschool and early school age,” says Samuel Sandboge, Postdoctoral Research Fellow at Tampere University.
“The results and their potential implications are interesting, but further research is needed to confirm the results. In the interpretation of the results, we must note, among other things, that we studied the psychiatric symptoms only as parent-reported. Furthermore, the participants of the study were children with Nordic ancestry living in Finland who had good levels of vitamin D,” Sandboge says.
The researchers found no differences in externalizing problems like aggression and rule breaking. Furthermore, no variations in the overall severity of psychiatric symptoms were discovered in the youngsters.
more recommended stories
-
CDKN2A Mutation: Friend or Foe in Esophageal Cancer?
In a groundbreaking study published in.
-
Nicotine May Reduce Inflammation and Boost Cognition in HIV
A recent study published in Neuropsychopharmacology.
-
AI System Tracks Emerging infectious Disease
Researchers have developed a novel method.
-
Ebola Virus Pathway Through Skin Unveiled
Ebola is a fatal hemorrhagic disease.
-
Why AI Doctors Struggle in Real-World Patient Interactions
A groundbreaking study from Harvard Medical.
-
Psilocybin Helps Reduce Anxiety, Depression During Cancer
Groundbreaking research from NYU Langone Health.
-
How Brain Structure Affects Early Substance Use in Teens
A recent study funded by the.
-
Smartphone App Reduces Opioid Use & Boosts Retention
According to a new study from.
-
RSV Vaccine Response in Immunocompromised Adults
According to Johns Hopkins Medicine researchers,.
-
Fatty Acid Metabolism Reprogramming in Liver Cancer Cells
A recent study published in Acta.
Leave a Comment